15q26 deletion in a patient with congenital heart defect, growth restriction and intellectual disability: case report and literature review

15q26 monosomy can occur either as a de novo event leading to a pure deletion or as a consequence of ring chromosome 15 formation and unbalanced translocation. Up to now, 58 cases of pure deletion have been documented in the literature [1, 2]. The sub-bands involved in this rearrangement include many candidate genes responsible for common symptoms, especially pre and postnatal growth retardation [3], developmental delay, microcephaly. Other genes were involved in more particular features like congenital heart disease (CHD) [4], skeletal anomalies [5], diaphragmatic hernia [6], kidney anomalies [1] and seizures [7]. This variability could be assigned to the difference in breakpoint location and the size of the deleted fragment. Recently, several authors focused on some particular regions especially the report of Klasseens et al., which restricted the critical region for congenital diaphragmatic hernia (CDH) to 4 Mb at 15q26.1-q26.3 band. Thus, two annotated genes, namely NR2F2 (MIM 107773) and CDH2 (MIM 602119), were considered relevant for CDH [8]. Other genes have been reported as playing crucial role in pathogenesis of 15q26 deletions, particularly IGF1R, CHD2, NR2F2, involved respectively in growth restriction [3], neurodevelopmental disorders [9], and CHD [4].

Herein, we report a further patient with CHD, intellectual disability and failure to thrive. Array-CGH displayed a terminal 9.15 Mb deletion spanning 15q26.1-q26.3, four relevant disease genes, i.e. IGF1R, NR2F2, MEF2A, and CHD2 were involved and are directly related to the clinical presentation of our case.

Until now, no patient had a deletion of this exact size, without similar works in the literature that already focused on the types of CHD assigned to the 15q26 deletion, or on other possible genotype-phenotype correlations.

The proband, a four-year-old girl, came to our attention because of dysmorphic face and heart malformation. She was the only child of healthy, consanguineous parents. There were no health problems in the family or a history of miscarriages. She was born at term by cesarean section because of intrauterine growth restriction (IUGR) associated with oligoamnios. IUGR was noted since the fourth month of pregnancy without that maternal or placental causes have been identified. Her birth weight was 950 g (< 3rd centile). Clinical history was suggestive of and congenital hypotonia. Upon clinical examination, her weight was 8 kg (< 3rd centile), height 81 cm (< 3rd centile) and head circumference 43 cm (< 3rd centile). She had dysmorphic features including broad forehead, hypertelorism, narrowed eyelid slits, low set ears, protruding columella, and short neck. She also presented with skeletal abnormalities, especially clinodactyly of the 5th finger, right foot varus equine, left club foot, biphalangeal fifth finger, and widely-spaced toes. Additionally, she had teething delay and divergent strabismus. Chest X-ray showed dorsal scoliosis and enlarged cardiac silhouette with a cardiothoracic ratio of 70%. An echocardiogram displayed a left-to-right shunt with significant flow, presence of two atrial septal defects (ASD) of 10 mm and 7 mm in width, dilating the right heart cavities and the pulmonary artery trunk with normal right pressures no aortic arch anomalies were evidenced. Her bone age was 2 years at a chronological age of 4 years. Hematologic investigations at the age of 4 and half years old showed normal serum concentrations of calcium, T4, TSH, GH and IGF1. Ocular assessment and brainstem acoustic potential evaluation revealed divergent strabismus and sensorineural hearing loss, respectively. Further investigations including brain MRI, computed tomography of the brain and abdominal ultrasound were normal.

Here we report a further case of “pure” terminal deletion 15q26 associated with complex CHD. Fifteen other cases with such aberration and CHD were previously described. Table 1 summarizes clinical and cytogenetic data in these patients and ours.

Our proband shares many relevant signs and symptoms with other patients, especially pre- and postnatal growth retardation, developmental delay, skeletal anomalies, microcephaly, and hearing defects. In the other patients eye anomalies were observed less frequently. Less common features were found in some cases including kidney anomaly, CDH and lung hypoplasia; however, these are lacking in our patient. Through this table, we also note that the CHD was most often described as complex, with several concomitant abnormalities like in our patient. Among the major cardiac defect there are ASD/VSD and aortic arch anomaly. Valvulopathy, patent ductus arteriosus, cardiac shunt and hypoplastic heart were rarely described. Our patient shared some of these anomalies, namely ASD and cardiac shunt. However, she lacked VSD, AAA and valvular defect. Cardiomegaly was an unusual feature reported exclusively in our patient. Indeed, the atrial septal defect resulted in the formation of significant shunts, which led to volume overload of the right atrium and ventricle and consequently our patient developed cardiomegaly.

Array analysis allowed us to characterize a 9.15 Mb deletion within the 15q26.1-q26.3 region. Comparable aberrations are often reported as de novo. Most often, terminal 15q deletions are found in combination with a terminal duplication of another chromosome due to an unbalanced translocation. To the best of our knowledge and according to the DECIPHER database, a deletion of this specific size has not been reported previously. Based on the Genome Data viewer (https://​www.​ncbi.​nlm.​nih.​gov/​genome/​gdv/​), the deleted segment encompasses 36 HGNC genes, 19 of them are referenced in the OMIM database, among which only IGF1R, NR2F2, CHD2 and MEF2A are consistent with the phenotype described in our proband: (Fig. 3).

IGF1R (insulin like growth factor 1 receptor) (MIM 147370) lies on the 15q26.3 locus. It is bound to the growth factor ligands IGF1 and IGF2 to play a key role in pre- and post-natal development [20, 21]. The crucial impact of IGF1R on growth processes was underlined by the growth restriction found in individuals with pathogenic variants in the IGF1R gene [3, 22], in addition to patients with a 15q26 deletion leading to haploinsufficiency [23]. To the best of our knowledge, no heart anomalies have ever seen in patients carrying IGF1 or IGF1R mutations nor in knockout mice lacking these genes. Therefore, it is unlikely that the onset of CHD is only caused by haploinsufficiency of the IGF1R gene [4].

NR2F2 (Nuclear NR2F2 (Nuclear Receptor Subfamily 2, Group F, Member 2) (MIM 107773), located at 15q26.2 locus, is involved in angiogenesis and heart development [24], Indeed, NR2F2 haploinsufficiency in patients with a 15q26 deletion appears to be associated with heart malformations [25]. In addition, variants within the NR2F2 gene were found to cause non-syndromic atrioventricular septal defects (AVSDs) and other heart defects as well [26] . Moreover, this gene has been implicated to be involved in some patients with diaphragmatic hernia [6, 27], but this was not reported in others [28, 29] nor present in our patient.

CHD2 (Chromodaine helicase DNA-binding protein) belongs to a family of ATP-dependant chromatin remodeling proteins involved in chromatin regulation [12]. Mutations in this gene were associated with severe non-syndromic intellectual disability [13], as well as epileptic encephalopathy [14]. Additionally, disruption of CHD2 was associated with scoliosis in murine models [15]. Interestingly, this anomaly was observed in our patient as well as a few in the literature [9, 16, 28]. These findings together highlight the involvement of CHD2 dysfunction in neurodevelopmental disorders and scoliosis. This gene has previously been proposed as a candidate gene for the CDH [8], but this was not evident in our case or elsewhere [7, 9]. MEF2A (Mads Box Transcription Enhancer Factor 2, Polypeptide A) (MIM 600660), mapped to the human chromosome 15q26.3 region, is member of the myocyte enhancer family of transcription factors (MEF2) [17]. The subunit MEF2A is expressed in endothelial and smooth muscle cells of coronary arteries. Subsequently, MEF2A mutations can disturb the growth or differentiation of these cells, increasing the risk of developing coronary artery disease (CAD)/ myocardial infarction (MI) [18, 19]. CAD/MI was not evident in patients with 15q26 deletion involving MEF2A. This could be explained by the relatively young age of these patients compared to others described by Wang and Bhagavatula whose age of diagnosis was between 36 and 80 years [18, 19]. Therefore, regular checking up would be useful from the third decade onwards in these patients.

To sum up, this work focused on the main genes whose haploinsufficiency could explain heart disease in patients with 15q26 monosomy, i.e. the NR2F2 gene involved respectively in AVSDs and AAA/hypoplastic left heart. Scoliosis and psychomotor delay in our patient would be explained by the CHD2 gene disruption. The phenotype in our patient could also be ascribed to the high rate of homozygous regions outlined by the CGH array, without excluding the possible contribution of epigenetic and environmental factors as well. 15q26 monosomy should be considered when growth retardation is associated with congenital heart defect (mainly AVSDs and/or AAA).

Patients with 15q26 deletion need a multidisciplinary management, which includes endocrinological assessment evaluating also possible GH therapy [30], as well as cardiologic, orthopedic and psychomotor follow-up. The genetic counseling in our family was delicate since the parents refused to undergo the array CGH analysis that is important for a complete familiar counseling.